Cell activation

Cell activation is a fundamental biological process where a cell transitions from a quiescent or resting state to a functionally active state in response to specific external stimuli, such as antigens, cytokines, or growth factors (Gene Ontology Consortium, GO:0001775). This transition involves a complex cascade of intracellular signaling events, including protein phosphorylation and second messenger release, which ultimately lead to significant changes in gene expression, metabolic activity, and the execution of effector functions (Abbas et al., Cellular and Molecular Immunology, 2021). In the immune system, the activation of T and B lymphocytes is critical for mounting an adaptive response; for example, T-cell activation requires the recognition of an antigen-MHC complex by the T-cell receptor along with essential costimulatory signals (Janeway et al., Immunobiology, 2001). Dysregulation of cell activation is a central feature of many pathologies, where excessive or chronic activation leads to autoimmune diseases and inflammatory disorders, while insufficient activation can result in immunodeficiency or the failure of cancer immunosurveillance. While many therapeutic agents, such as calcineurin inhibitors or immune checkpoint inhibitors, are designed to modulate these pathways, "cell activation" itself is a broad physiological phenomenon rather than a single, discrete molecular drug target (NIH/NCBI MeSH, 2023). Consequently, it is categorized as a biological process that serves as the functional endpoint for various molecular interventions.

Other names

Cellular activationImmune activationLymphocyte activationLeukocyte activation

Drugs modulate cell activation by targeting specific molecular components of signaling pathways, such as surface receptors (e.g., TCR, PD-1), intracellular kinases (e.g., JAK, BTK), or phosphatases (e.g., Calcineurin), to either suppress or enhance the resulting cellular response.